Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AANAT | Q16613 | 1/20 | 0.75 |
| ▸ | MEN1 | O00255 | 6/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.73 |
| ▸ | LMNA | P02545 | 1/20 | 0.70 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.70 |
| ▸ | PKM | P14618 | 1/20 | 0.70 |
| ▸ | TSHR | P16473 | 1/20 | 0.70 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.70 |
| ▸ | BLM | P54132 | 1/20 | 0.70 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.68 |
| ▸ | MMP9 | P14780 | 1/20 | 0.67 |
| ▸ | NPC1 | O15118 | 1/20 | 0.67 |
| ▸ | RAB9A | P51151 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 2/20 | 0.65 |
| ▸ | GAA | P10253 | 1/20 | 0.65 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.64 |
| ▸ | FAAH | O00519 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19051489 | 0.90 | MEN1 (0.80) | AANATMEN1KMT2ALMNACYP1A2 | |
| SCHEMBL10069200 | 0.87 | AANAT (0.77) | AANATMEN1KMT2ALMNACYP1A2 | |
| SCHEMBL5903804 | 0.87 | AANAT (0.77) | AANATMEN1KMT2ALMNACYP1A2 | |
| SCHEMBL7677886 | 0.87 | MEN1 (0.84) | AANATMEN1KMT2ALMNACYP1A2 | |
| SCHEMBL2824956 | 0.87 | MEN1 (0.83) | AANATMEN1KMT2ALMNACYP1A2 | |
| SCHEMBL6424904 | 0.86 | AANAT (0.75) | AANATMEN1KMT2ALMNACYP1A2 | |
| SCHEMBL761155 | 0.86 | MTNR1A (0.76) | AANATMEN1KMT2ALMNACYP1A2 | |
| SCHEMBL31114206 | 0.86 | MTNR1A (0.76) | AANATMEN1KMT2ALMNACYP1A2 | |
| SCHEMBL6424908 | 0.86 | AANAT (1.00) | AANATMEN1KMT2ALMNACYP1A2 | |
| SCHEMBL20227977 | 0.86 | AANAT (0.75) | AANATMEN1KMT2ALMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025264058-A9 | NOVEL COMPOUND AND USE THEREOF | 주식회사 진큐어 | 2026-02-26 | — | — | WO | disclosed |
| US-20040102488-A1 | Butenolide and pentenolide derivatives as kinase inhibitors | MORPHOCHEM AG (DE) | 2004-05-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040102488-A1 | Butenolide and pentenolide derivatives as kinase inhibitors | MAP3K20, MAP3K21, MAP3K1 | AANAT 2629/4885MEN1 2347/4885KMT2A 3752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.